It's not a new question, but it's one whose urgency is growing: How long can Pfizer pay its big dividend? It's the largest in the industry, at 6.67 percent compared with 3.37 percent pharma-wide.
On the same day that Ted Kennedy was undergoing brain surgery to remove a tumor,
> News yesterday that Acorda Therapeutics' experimental MS drug helped patients walk better sent its shares up 27 percent.
Talk about an image being worth a thousand words. A Wall Street Journal chart tracking new Chantix prescriptions since January shows the kind of downward slope you only want to see on a double black
Hit by new concerns about the safety of its stop-smoking drug Chantix, Pfizer is hitting back with an advertising and PR campaign. And no wonder: The drugmaker has been counting on that drug, with
It's a brave new pharma-marketing world out there, with more and more hospitals and docs barring drug reps and companies turning to electronic detailing to get their messages across. But the online
Say hello to Pfizer's new general counsel, Amy Schulman (photo), a top litigator who's served as lead attorney on
Exploiting a competitor's weakness is a time-honored tradition in business. So it's probably no surprise that GlaxoSmithKline is injecting itself into the
Trucking regulators have joined the FAA in banning Pfizer's stop-smoking drug among its drivers. The Federal Motor Carrier Safety Administration yesterday said Chantix patients shouldn't be
Chantix suffered a one-two punch yesterday, as a watchdog group's report linked the stop-smoking med to a wide variety of health and safety problems, and the Federal Aviation Administration told